Inhibiting CDK9 activity also suppressed the expressions of the stemness markers in the two NSCLC cell lines-SOX2, OCT4, NANOG and KIF4, while also significantly inhibiting other stemness phenotypes like Side Population (SP) and serum-free suspension culture. The gene discussed is CDK9; the disease is non-small cell lung carcinoma.